Press Releases
Search
-
12 May 2009
2009 ESCMID/bioMérieux Research Grant in Clinical Microbiology
Winner Conducting Research on Major Cause of Healthcare-Associated Infections Marcy l’Etoile, France - May 12, 2009. bioMérieux, a world leader in in vitro diagnostics, and the European Society of Cli...
-
30 Apr 2009
Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2008
Marcy l'Etoile, France - April 30, 2009. La Société annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son rapport financier annuel au 31 décembre 2008.
-
23 Apr 2009
First-Quarter 2009 Business Review: Sales Growth in Line with Objectives
Marcy l'Etoile, France - April 23, 2009. Up 6.4% - At constant exchange rates and scope of consolidation. Up 10.6% - At constant exchange rates, including business development agreements. bioMérieux, ...
-
23 Apr 2009
bioMérieux - First-Quarter 2009 Business Review
Marcy l'Etoile, France - April 23, 2009. Up 6.4% - At constant exchange rates and scope of consolidation. Up 10.6% - At constant exchange rates, including business development agreements. bioMérieux, ...
-
07 Apr 2009
bioMérieux Unveils its Groundbreaking Culture Media Range for Sterility Control of Aseptic Pharmaceutical Plants
Marcy l'Etoile, France - April 7, 2009. New range will simplify testing for the pharmaceutical industry. bioMérieux, a world leader in the field of in vitro diagnostics and a leading provider of micro...
-
20 Jan 2009
bioMérieux - 2008 Business Review
Marcy l'Etoile, France - January 20, 2009. bioMérieux, a global leader in the field of in vitro diagnostics, released its business review for fourth-quarter and full-year 2008. 2008 Sales Up 7.5% at c...
-
15 Jan 2009
bioMérieux’s New TEMPO® Solution Delivers Rapid Results on Direct Enumeration of Yeast and Molds to Improve Food Safety
Marcy l’Etoile, France - January 15, 2009. bioMérieux, a world leader in the field of in vitro diagnostics, is enhancing its TEMPO® line for food quality with the launch of one of the most rapid autom...
-
22 Dec 2008
Appointment of Alexandre Mérieux by the bioMérieux Board of Directors
Marcy l'Etoile, France - December 22, 2008. At the meeting of the bioMérieux Board of Directors held on December 19, 2008, Alexandre Mérieux was appointed as “Directeur Général Délégué” of the Company...
-
14 Dec 2008
bioMérieux Receives Prestigious Frost & Sullivan 2008 North American Market Leadership Award for Pharmaceutical Microbiology
bioMérieux recognized for outstanding strategic vision in U.S. Rapid Pharmaceutical Manufacturing Microbiology Tests Market Marcy l’Etoile, France - October 14, 2008. bioMérieux, a world leader in the...
-
08 Dec 2008
bioMérieux Acquires Culture Media Specialist PML Microbiologicals
bioMérieux’s recurring sales will be boosted by expanded reagent range Marcy l'Etoile, France - December 8, 2008. bioMérieux, a world leader in the field of in vitro diagnostics has acquired PML Micro...
-
28 Oct 2008
bioMérieux Business review for the nine months ended September 30, 2008
Marcy l'Etoile, France - October 28, 2008. bioMérieux, a global leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2008. 2008 Nine-...
-
23 Oct 2008
bioMérieux Opens a Subsidiary in the Middle East, Continuing its International Growth
Marcy l’Etoile, France - October 23, 2008. bioMérieux, a world leader in the field of in vitro diagnostics, announces the opening of a subsidiary in the United Arab Emirates. A hub for its operations ...
-
25 Sep 2008
bioMérieux to Develop New Highly-Specific, Non-invasive Test for Prostate Cancer, Reducing Unnecessary Biopsies
Marcy l'Etoile, France - September 25, 2008. Prostate cancer is the most prevalent cancer in the United States and the 4th most common worldwide. The combination of a test for a new prostate cancer bi...
-
11 Sep 2008
bioMérieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx
Marcy l'Etoile, France - September 11, 2008. bioMérieux, a world leader in the field of in vitro diagnostics has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, b...
-
08 Sep 2008
First-Half 2008 Financial Report Sustained sales growth while consolidating profitability - Operating income before non-recurring items up 7.6%
Marcy l'Etoile, France - September 8, 2008. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its interim financial report for the first six months of 20...